2nd Quarter - Termination
NOVEL STRATEGIES (FKA) PRISM GROUP for GENEVANT SCIENCES, INC.
Client
Income
$40,000
Expenses
—
Terminated
May 31, 2025
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Healthcare matters
Foreign entity interest: Per initial registration: Genevant Sciences Holdings Limited (GSHL) Main address: United Kingdom (GBR) Principal place of business: United Kingdom (GBR) Genevant Sciences Ltd. (GSL) Main address: Bermuda (BER) Principal place of business: United Kingdom (GBR) Roivant Sciences Ltd Main address: Bermuda (BER) Principal place of business: United Kingdom (GBR)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAY BRETT PERRON | n/a |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.